Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Mild to Moderate Aortic Stenosis
NCT00800800Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2002
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in aortic stenosis (AS), sponsored by AstraZeneca. Started Nov 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT00800800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800800.